OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Axonal degeneration induced by glutamate excitotoxicity is mediated by necroptosis
Diego E. Hernández, Natalia Salvadores, Guillermo Moya‐Alvarado, et al.
Journal of Cell Science (2018) Vol. 131, Iss. 22
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

A guide to cell death pathways
Junying Yuan, Dimitry Ofengeim
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 5, pp. 379-395
Closed Access | Times Cited: 291

Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection
Shruti Shandilya, Sandeep Kumar, Niraj Kumar Jha, et al.
Journal of Advanced Research (2021) Vol. 38, pp. 223-244
Open Access | Times Cited: 182

Axonal energy metabolism, and the effects in aging and neurodegenerative diseases
Sen Yang, Jung Hyun Park, Hui‐Chen Lu
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 46

Neuronal Autophagy Regulates Presynaptic Neurotransmission by Controlling the Axonal Endoplasmic Reticulum
Marijn Kuijpers, Gaga Kochlamazashvili, Alexander Stumpf, et al.
Neuron (2020) Vol. 109, Iss. 2, pp. 299-313.e9
Open Access | Times Cited: 124

SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration
Kwang Woo Ko, Jeffrey Milbrandt, Aaron DiAntonio
The Journal of Cell Biology (2020) Vol. 219, Iss. 8
Open Access | Times Cited: 116

The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease
Maritza Oñate, Alejandra Catenaccio, Natalia Salvadores, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 4, pp. 1169-1185
Open Access | Times Cited: 96

Advances in microfluidic in vitro systems for neurological disease modeling
Paul M. Holloway, Sandrine Willaime‐Morawek, Richard Siow, et al.
Journal of Neuroscience Research (2021) Vol. 99, Iss. 5, pp. 1276-1307
Open Access | Times Cited: 78

Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Natalia Salvadores, Inés Moreno‐González, Nazaret Gamez, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 50

Blood brain barrier-on-a-chip to model neurological diseases
S. Reshma, K. B. Megha, S. Amir, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 80, pp. 104174-104174
Closed Access | Times Cited: 17

Axonal Degeneration in AD: The Contribution of Aβ and Tau
Natalia Salvadores, Cristian Gerónimo‐Olvera, Felipe A. Court
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 49

Excitotoxicity Revisited: Mitochondria on the Verge of a Nervous Breakdown
Nicoletta Plotegher, Riccardo Filadi, Paola Pizzo, et al.
Trends in Neurosciences (2021) Vol. 44, Iss. 5, pp. 342-351
Open Access | Times Cited: 40

Roles and Mechanisms of Axon-Guidance Molecules in Alzheimer’s Disease
Lei Zhang, Zhipeng Qi, Jiashuo Li, et al.
Molecular Neurobiology (2021)
Closed Access | Times Cited: 36

Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment
Shang Li, Lailiang Qu, Xiaobing Wang, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107979-107979
Closed Access | Times Cited: 33

Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities
Ruxin Zhang, Yanrong Song, Xuefeng Su
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S367-S386
Open Access | Times Cited: 24

Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation
Macarena S. Arrázola, Matías Lira, Felipe Véliz‐Valverde, et al.
Aging Cell (2023) Vol. 22, Iss. 5
Open Access | Times Cited: 15

Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases
Rohan Gupta, Kumari Smita, Rahul Tripathi, et al.
Ageing Research Reviews (2023) Vol. 86, pp. 101855-101855
Closed Access | Times Cited: 14

Calcium Dyshomeostasis Drives Pathophysiology and Neuronal Demise in Age-Related Neurodegenerative Diseases
Gerard Griffioen
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13243-13243
Open Access | Times Cited: 14

Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases
Narjes Shahsavani, Hardeep Kataria, Soheila Karimi‐Abdolrezaee
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1867, Iss. 6, pp. 166117-166117
Closed Access | Times Cited: 30

Cis- and trans-resveratrol have opposite effects on histone serine-ADP-ribosylation and tyrosine induced neurodegeneration
Megha Jhanji, C.N.R. Rao, Jacob C. Massey, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21

Diverse pathways to neuronal necroptosis in Alzheimer's disease
Anusha Jayaraman, Richard Reynolds
European Journal of Neuroscience (2022) Vol. 56, Iss. 9, pp. 5428-5441
Closed Access | Times Cited: 19

Purine Metabolism and Dystonia: Perspectives of a Long‐Promised Relationship
Ugo Sorrentino, Audrey G. O’Neill, Justin M. Kollman, et al.
Annals of Neurology (2025)
Open Access

Targeting necroptosis in Alzheimer’s disease: can exercise modulate neuronal death?
Di Lu, Wenyu Zhang, Ruiyu Li, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access

NMDA Receptors: Next therapeutic targets for Tinnitus?
Chenhao Che, Yongzhen Wu, Shan Sun
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 102029-102029
Closed Access

Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease
Satyam Pati, Avtar Singh Gautam, Mangaldeep Dey, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103750-103750
Closed Access | Times Cited: 10

Page 1 - Next Page

Scroll to top